Sugi Predict

Sugi Predict / Compounds / SCHEMBL1385182

SCHEMBL1385182

SCHEMBL1385182

CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2C=Nc1ccccc1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TOP1 P11387 19/20 0.83
▸ ALDH1A1 P00352 3/20 0.64
▸ GLA P06280 3/20 0.64
▸ KDM4E B2RXH2 2/20 0.64
▸ TP53 P04637 2/20 0.64
▸ HPGD P15428 2/20 0.64
▸ MEN1 O00255 2/20 0.64
▸ KMT2A Q03164 2/20 0.64
▸ SMN1; SMN2 Q16637 2/20 0.64
▸ STAT6 P42226 1/20 0.64
▸ CHEK1 O14757 1/20 0.64
▸ HDAC3 O15379 1/20 0.64
▸ ABCC4 O15439 1/20 0.64
▸ GMNN O75496 1/20 0.64
▸ LMNA P02545 1/20 0.64
▸ CYP1A2 P05177 1/20 0.64
▸ CYP3A4 P08684 1/20 0.64
▸ HNRNPA1 P09651 1/20 0.64
▸ GAA P10253 1/20 0.64
▸ ALOX15 P16050 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5014520 0.95 TOP1 (0.78) TOP1ALDH1A1GLAKDM4ETP53
SCHEMBL1381473 0.95 TOP1 (0.81) TOP1ALDH1A1GLAKDM4ETP53
SCHEMBL28759768 0.95 TOP1 (0.78) TOP1ALDH1A1GLAKDM4ETP53
SCHEMBL5012974 0.95 TOP1 (0.77) TOP1ALDH1A1GLAKDM4ETP53
SCHEMBL5011258 0.94 TOP1 (0.76) TOP1ALDH1A1GLAKDM4ETP53
SCHEMBL5011496 0.93 TOP1 (0.75) TOP1ALDH1A1GLAKDM4ETP53
SCHEMBL1386720 0.92 TOP1 (0.73) TOP1ALDH1A1GLAKDM4ETP53
SCHEMBL2929566 0.92 TOP1 (0.80) TOP1ALDH1A1GLAKDM4ETP53
SCHEMBL26514712 0.92 TOP1 (0.80) TOP1ALDH1A1GLAKDM4ETP53
SCHEMBL5012704 0.91 TOP1 (0.72) TOP1ALDH1A1GLAKDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4791355-B2 — — 2011-10-12 — — JP claimed
JP-2006520807-A — — 2006-09-14 — — JP claimed
US-7105492-B2 Camptothecin derivatives having antitumor activity SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2006-09-12 — — US claimed
US-20060167033-A1 7-Imino derivatives of camptothecin having antitumor activity ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI (IT) 2006-07-27 — — US claimed
EP-1603919-A1 7-IMINO DERIVATIVES OF CAMPTOTHECIN HAVING ANTITUMOR ACTIVITY Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) 2005-12-14 — — EP claimed
WO-2004083214-A1 7-IMINO DERIVATIVES OF CAMPTOTHECIN HAVING ANTITUMOR ACTIVITY SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2004-09-30 — — WO claimed
US-20040018988-A1 Camptothecin derivatives having antitumor activity SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2004-01-29 — — US claimed
US-6589939-B2 Also useful in treating viral infections; antiprotozoa (plasmodium) activity SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2003-07-08 — — US claimed
US-20010008939-A1 Camptothecin derivatives having antitumor activity SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.. 2001-07-19 — — US claimed
EP-1044977-A1 Camptothecin derivatives having antitumor activity Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) 2000-10-18 — — EP claimed
WO-2000053607-A1 CAMPTOTHECIN DERIVATIVES HAVING ANTITUMOR ACTIVITY SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2000-09-14 — — WO claimed
US-7351714-B2 7-imino derivatives of camptothecin having antitumor activity SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2008-04-01 — — US disclosed
US-7105492-B2 Camptothecin derivatives having antitumor activity SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2006-09-12 — — US disclosed
US-20060167033-A1 7-Imino derivatives of camptothecin having antitumor activity ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI (IT) 2006-07-27 — — US disclosed
EP-1603919-A1 7-IMINO DERIVATIVES OF CAMPTOTHECIN HAVING ANTITUMOR ACTIVITY Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) 2005-12-14 — — EP disclosed
US-6589939-B2 Also useful in treating viral infections; antiprotozoa (plasmodium) activity SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2003-07-08 — — US disclosed
US-20010008939-A1 Camptothecin derivatives having antitumor activity SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.. 2001-07-19 — — US disclosed
US-6242457-B1 OXIME DERIVATIVES SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2001-06-05 — — US disclosed
EP-1044977-A1 Camptothecin derivatives having antitumor activity Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) 2000-10-18 — — EP disclosed
WO-2000053607-A1 CAMPTOTHECIN DERIVATIVES HAVING ANTITUMOR ACTIVITY SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2000-09-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167033-A1 7-Imino derivatives of camptothecin having antitumor activity TYMP, TOP1, TOP2A TOP1 2/4885ALDH1A1 2013/4885GLA 2726/4885
US-20010008939-A1 Camptothecin derivatives having antitumor activity TOP1, TOP2A, TYMP TOP1 1/4885ALDH1A1 2202/4885GLA 1623/4885
US-20040018988-A1 Camptothecin derivatives having antitumor activity TOP1, TOP2A, TOP2B TOP1 1/4885ALDH1A1 1248/4885GLA 1972/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.